NCT05903781Completed
Value of Ultra-fast Prostate MRI in Prostate Cancer
Value of Ultra-fast Biparametric MRI in the Assessment of Prostate Cancer
Source: ClinicalTrials.gov · Last updated 14 May 2025
Brief summary (registry, in English)
This study aims to assess the value of ultra-fast MRI sequences in the assessment of prostate cancer, compared to the full multiparametric/biparametric protocol as the clinical standard.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 536 (actual)
- First submitted
- 31 May 2023
- Start date
- 26 Jun 2023
- Primary completion date
- 18 Feb 2025
- Lead sponsor
- University of Zurich
- Diseases
- Prostate cancer
- NCT number
- NCT05903781
What you commit to
- Study type: Observational
- Participants enrolled: 536
- From 26 Jun 2023 to the primary completion date, 18 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous enrolment into the current study
Other illness
- Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant
- Patients with non-MRI compatible metallic or electronic implants, devices or metallic foreign bodies (cardiac pacemaker, shrapnel, cochlea implants, neurostimulator, or other non-MRI compatible implants).
- Patients with known hypersensitivity reactions to MRI contrast agents will undergo the examination without application of a contrast agent
Other
- Enrolment of the investigator, his/her family members, employees and other dependent persons
Who the study is looking for
- Patients who undergo clinically indicated MR imaging of the prostate
- Informed consent as documented by signature (Informed Consent Form)
- Patients ≥18 years of age
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Zurich Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.